|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.80 CNY | -0.29% |
|
+2.87% | -21.93% |
| 07-09 | Huadong Medicine's Attributable Profit Jumps 9.6% in H1 | MT |
| 06-26 | Huadong Medicine Gets Clinical Trial Approval for Cancer Drug; Shares Down 3% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.45% | 2.74% | 13.87x | 1.97x | 1.06x | 8.56x | 10.29x | 8B | ||
| 0.4% | 0.43% | 19.6x | -39.96x | 0.24x | 13.56x | 14.48x | 97.04B | ||
| 0.92% | 0.92% | 29.19x | -22.89x | 0.23x | 14.67x | 16.64x | 53.19B | ||
| 1.36% | 1.66% | 45.45x | 6.71x | 3.21x | 29.79x | 31.73x | 23.38B | ||
| 2.6% | 2.86% | 11.65x | 0.77x | 0.2x | 4.89x | 6.09x | 8.26B | ||
| 3.51% | 3.59% | 9.36x | 1.48x | 1.75x | 5.59x | 7.47x | 6.27B | ||
| 2.83% | 2.98% | 25.18x | 2.91x | 1.23x | 15.17x | 21.69x | 5.5B | ||
| 4.12% | 4.39% | 10.85x | 0.86x | 0.12x | 4.5x | 5.89x | 3.73B | ||
| 2.38% | 2.46% | 14.26x | 0.77x | - | - | - | 3.58B | ||
| 0.18% | 0.38% | 32.12x | - | 0.55x | 10.99x | 12.24x | 3.17B | ||
| 3.13% | 3.42% | 9.99x | 1.05x | - | - | - | 3.1B | ||
| 5.34% | 5.16% | 15.65x | 1.37x | 0.36x | 7.85x | 10.3x | 2.67B | ||
| 2.06% | 2.25% | 14.23x | 0.81x | - | - | - | 2.15B | ||
| 2.8% | 2.93% | 10.8x | 0.65x | 0.17x | 5.36x | 6.45x | 1.75B | ||
| 4.46% | 4.03% | 19.95x | 0.94x | - | - | - | 1.6B | ||
| 0.47% | 0.49% | 19.96x | 2.65x | 0.46x | 10.06x | 14.37x | 1.31B | ||
| Average | 2.44% | 2.54% | 18.88x | -2.66x | 0.80x | 10.92x | 13.14x | 14.04B | |
| Weighted average by Cap. | 1.17% | 1.25% | 23.56x | -21.98x | 0.66x | 14.54x | 16.10x |
- Stock Market
- Stocks
- 000963 Stock
- Sector Huadong Medicine Co., Ltd
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















